NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Thursday, June 22, 2017
ATTENTION: The FDA announced on March 30, 2007, that the maker of the drug Zelnorm (generic name: tegaserod maleate) has agreed to stop marketing the drug due to health safety concerns.
If you are taking Zelnorm (tegaserod maleate), you should consult with your physician as soon as possible about stopping the medication and your treatment alternatives.
For more information, please follow the link below:
This article is a NetWellness exclusive.
Last Reviewed: Apr 02, 2007
Peter J Embi, MD, MS
College of Medicine
University of Cincinnati